Geneventiv Therapeutics Licenses Gene Therapy for Hemophilia

Geneventiv Therapeutics Licenses Gene Therapy for Hemophilia

by | Oct 30, 2020 | Press

GeneVentiv Therapeutics and University of North Carolina Chapel Hill Enter License Agreement RALEIGH, NC, November 2, 2020 — GeneVentiv Therapeutics, Inc. has entered into a license agreement with the University of North Carolina Chapel Hill for a patent pending, gene...